BIS — ProShares UltraShort Nasdaq Biotechnology

—
NMS · Derivatives · Trading · CIK ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
No quarterly fundamentals indexed for this ticker.

Max Pain — expiry 2027-05-21 (volume-derived — Yahoo OI feed degraded)

max pain strike: $9.00 · spot: $11.40 · call volume: 12 · put volume: 6

News headlines (Yahoo Finance, 1h cache)

3 ASX Penny Stocks Under A$400M Market Cap To Consider
2026-04-17 03:05 · Yahoo
ProShares Announces ETF Share Splits
2026-05-11 22:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.